SlideShare uma empresa Scribd logo
1 de 6
Baixar para ler offline
INSTRUCTIONS
0412.423235
Micro BCA™ Protein Assay Kit
Number Description
23235 Micro BCA Protein Assay Kit, sufficient reagents for 480 tube assays or 3,200 microplate assays
Kit Contents:
Micro BCA Reagent A (MA), 240 ml
Micro BCA Reagent B (MB), 240 ml
Micro BCA Reagent C (MC), 12 ml
Albumin Standard Ampules, 2 mg/ml, 10 × 1 ml ampules containing bovine serum albumin (BSA)
at 2.0 mg/ml in a solution of 0.9% saline and 0.05% sodium azide
Storage: Upon receipt store product at room temperature. Product shipped at ambient temperature.
Note: If either Reagent MA or Reagent MB precipitates upon shipping in cold weather or during long-
term storage, dissolve precipitates by gently warming and stirring solutions. Discard any reagent that
shows discoloration or evidence of microbial contamination.
Table of Contents
Introduction .................................................................................................................................................................................1
Preparation of Standards and Working Reagent..........................................................................................................................2
Test Tube Procedure (linear working range of 0.5-20 µg/ml) .....................................................................................................3
Microplate Procedure (linear working range of 2-40 µg/ml).......................................................................................................3
Troubleshooting...........................................................................................................................................................................3
Additional Information ................................................................................................................................................................4
Related Products..........................................................................................................................................................................5
References ...................................................................................................................................................................................5
Introduction
The Thermo Scientific Micro BCA Protein Assay Kit is a detergent-compatible bicinchoninic acid formulation for the
colorimetric detection and quantitation of total protein. An adaptation of the Thermo Scientific Pierce BCA Protein Assay Kit
(Product No. 23225), the Micro BCA Kit has been optimized for use with dilute protein samples (0.5-20 μg/ml). The unique,
patented method utilizes bicinchoninic acid (BCA) as the detection reagent for Cu+1
, which is formed when Cu+2
is reduced
by protein in an alkaline environment.1
A purple-colored reaction product is formed by the chelation of two molecules of
BCA with one cuprous ion (Cu+1
). This water-soluble complex exhibits a strong absorbance at 562 nm that is linear with
increasing protein concentrations.
The macromolecular structure of protein, the number of peptide bonds and the presence of four amino acids (cysteine,
cystine, tryptophan and tyrosine) are reported to be responsible for color formation with BCA.2
Studies with di-, tri- and
tetrapeptides suggest that the extent of color formation is caused by more than the mere sum of individual color-producing
functional groups.2
The Micro BCA Protein Assay Kit uses concentrated reagents and a protocol that utilizes an extended incubation time at an
elevated temperature (60°C, Test Tube Procedure only). The result is an extremely sensitive colorimetric protein assay in a
test tube or microplate assay format.
Pierce Biotechnology PO Box 117 (815) 968-0747 www.thermo.com/pierce
3747 N. Meridian Road Rockford, lL 61105 USA (815) 968-7316 fax
Preparation of Standards and Working Reagent
A. Preparation of Diluted Albumin (BSA) Standards
Use Table 1 as a guide to prepare a set of protein standards. Dilute the contents of one Albumin (BSA) Standard ampule into
several clean vials, preferably using a diluent that is similar to the sample buffer. Each 1 ml ampule of 2.0 mg/ml Albumin
Standard is sufficient to prepare a set of diluted standards such that three replicates of each dilution may be included in the
Test Tube Procedure.
Table 1. Preparation of Diluted Albumin (BSA) Standards
Vial Volume of Diluent Volume and Source of BSA Final BSA Concentration
A 4.5 ml 0.5 ml of Stock 200 μg/ml
B 8.0 ml 2.0 ml of vial A dilution 40 μg/ml
C 4.0 ml 4.0 ml of vial B dilution 20 μg/ml
D 4.0 ml 4.0 ml of vial C dilution 10 μg/ml
E 4.0 ml 4.0 ml of vial D dilution 5 μg/ml
F 4.0 ml 4.0 ml of vial E dilution 2.5 μg/ml
G 4.8 ml 3.2 ml of vial F dilution 1 μg/ml
H 4.0 ml 4.0 ml of vial G dilution 0.5 μg/ml
I 8.0 ml 0 0 μg/ml = Blank
B. Preparation of the Micro BCA Working Reagent (WR)
1. Use the following formula to determine the total volume of WR required:
(# standards + # unknowns) × (# replicates) × (volume of WR per sample) = total volume WR required
Example: for the standard Test Tube Procedure with 3 unknowns and 2 replicates of each sample:
(9 standards + 3 unknowns) × (2 replicates) × (1 ml) = 24 ml WR required (round up to 25 ml)
Note: 1 ml of the WR is required for each sample in the Test Tube Procedure, while only 150 µl of WR is required
for each sample in the Microplate Procedure.
2. Prepare WR by mixing 25 parts of Micro BCA Reagent MA and 24 parts Reagent MB with 1 part of Reagent MC
(25:24:1, Reagent MA:MB:MC). For the above example, combine 12.5 ml of Reagent MA and 12.0 ml Reagent MB
with 0.5 ml of Reagent MC.
Note: When Reagent MC is initially added to Reagents MA and MB, turbidity occurs that quickly disappears upon
mixing to yield a clear-green solution. Prepare sufficient volume of WR based on the number of samples to be assayed.
The WR is stable for one day when stored in a closed container at room temperature (RT). It is not necessary to protect
the solution from light.
Procedure Summary (Test Tube Procedure)
Pierce Biotechnology PO Box 117 (815) 968-0747 www.thermo.com/pierce
3747 N. Meridian Road Rockford, lL 61105 USA (815) 968-7316 fax
2
Pierce Biotechnology PO Box 117 (815) 968-0747 www.thermo.com/pierce
3747 N. Meridian Road Rockford, lL 61105 USA (815) 968-7316 fax
3
Test Tube Procedure (linear working range of 0.5-20 µg/ml)
1. Pipette 1.0 ml of each standard and unknown sample replicate into appropriately labeled test tubes.
2. Add 1.0 ml of the WR to each tube and mix well.
3. Cover tubes and incubate at 60°C in a water bath for 1 hour.
4. Cool all tubes to room temperature (RT).
5. With the spectrophotometer set to 562 nm, zero the instrument on a cuvette filled only with water. Subsequently,
measure the absorbance of all the samples within 10 minutes.
Note: Color development continues even after cooling to RT. However, the rate of development at RT is sufficient low
that no significant error is introduced if all absorbance measurements are made within a 10 minute period.
6. Subtract the average 562 nm absorbance reading of the Blank standard replicates from the 562 nm reading of all other
individual standard and unknown sample replicates.
7. Prepare a standard curve by plotting the average Blank-corrected 562 nm reading for each BSA standard vs. its
concentration in µg/ml. Use the standard curve to determine the protein concentration of each unknown sample.
Microplate Procedure (linear working range of 2-40 µg/ml)
1. Pipette 150 µl of each standard or unknown sample replicate into a microplate well (Product No. 15041).
2. Add 150 µl of the WR to each well and mix plate thoroughly on a plate shaker for 30 seconds.
3. Cover plate using Sealing Tape for 96-Well Plates (Product No. 15036) and incubate at 37°C for 2 hours.
Note: Limit incubations of microplate to less than or equal to 37°C, otherwise high background and aberrant color
development may result. Most polystyrene assay plates deform, leach, and become cloudy at 60°C.
4. Cool plate to room temperature (RT).
5. Measure the absorbance at or near 562 nm on a plate reader.
6. Subtract the average 562 nm absorbance reading of the Blank standard replicates from the 562 nm reading of all other
individual standard and unknown sample replicates.
7. Prepare a standard curve by plotting the average Blank-corrected 562 nm reading for each BSA standard vs. its
concentration in µg/ml. Use the standard curve to determine the protein concentration of each unknown sample.
Note: If using curve-fitting software, use a best-fit polynomial equation rather than a linear equation for the standard
curve. If plotting results by hand, a point-to-point fit is preferable to a linear fit to the standard points.
Troubleshooting
Problem Possible Cause Solution
No color in any tubes Sample contains a copper chelating agent Dialyze, desalt, or dilute sample
Increase copper concentration in working
reagent (e.g., use more Reagent MC)
Strong acid or alkaline buffer, alters
working reagent pH
Dialyze, desalt, or dilute sampleBlank absorbance is OK, but
standards and samples show
less color than expected Color measured at the wrong wavelength Measure the absorbance at 562 nm
Protein concentration is too high Dilute sampleColor of samples appears
darker than expected Sample contains lipids or lipoproteins Add 2% SDS to the sample3
Buffer contains a reducing agent
Buffer contains a thiol
All tubes (including blank) are
dark purple
Buffer contains biogenic amines
(catecholamines)
Dialyze or dilute sample
Need to measure color at a
different wavelength
Spectrophotometer or plate reader does
not have 562 nm filter
Wavelengths between 540 nm and 590 nm
can be used, but standard curve slope and
overall assay sensitivity will be decreased.
See Tech Tip on web site
Additional Information
A. Interfering Substances
Certain substances are known to interfere with the Micro BCA Assay including those with reducing potential, chelating
agents, and strong acids or bases. Avoid the following substances as components of the sample buffer:
Ascorbic Acid Hydrogen Peroxide Iron Reducing Sugars
Catecholamines Hydrazides Lipids Tryptophan
Cysteine Impure Glycerol Phenol Red Tyrosine
EGTA Impure Sucrose Reducing Agents Uric Acid
Maximum compatible concentrations for many substances in the Test Tube Procedure are listed in Table 2 (see last page).
Substances were considered compatible at the indicated concentration if the error in protein concentration estimation caused
by the presence of the substance in the sample was less than or equal to 10%. The substances were tested using WR prepared
immediately before each experiment. The Blank-corrected 562 nm absorbance measurements (for the 10 µg/ml BSA standard
+ substance) were compared to the net 562 nm readings of the same standard prepared in 0.9% saline.
B. Strategies for Eliminating or Minimizing the Effects of Interfering Substances
The effects of interfering substances in the Micro BCA Protein Assay may be eliminated or overcome by several methods.
• Remove the interfering substance by dialysis or gel filtration (see Related Pierce Products).
• Dilute the sample until the substance no longer interferes. (This is only effective for relatively concentrated samples.)
• Precipitate proteins with acetone or trichloroacetic acid (TCA).4
• Increase the amount of copper in the WR (prepare WR using a greater proportion of Reagent MC; e.g., MA:MB:MC
equal to 25:24:2 or 25:24:3), which may eliminate interference by copper chelating agents.
Note: For greatest accuracy, the protein standards must be treated identically to the sample(s).
C. Response Characteristics for Different Proteins
Each of the commonly used total protein assay methods exhibits some degree of varying response toward different proteins
(Table 3). These differences relate to amino acid sequence, pI, structure and the presence of certain side chains or prosthetic
groups that can dramatically alter the protein’s color response. Most protein assay methods use BSA or immunoglobulin
(IgG) as the standard against which the concentration of protein in the sample is determined. Pierce Albumin Standard (BSA)
(Product No. 23209) provides a consistent standard for protein estimations. Nevertheless, individual proteins, including BSA
and IgG, differ slightly in their color responses in the Micro BCA Assay (Figure 1). Therefore, for maximum accuracy use a
purified (known concentration) sample of the target protein as the assay standard.
Table 3. Protein-to-Protein Variation. Absorbance ratios
(562 nm) for proteins relative to BSA using the Test Tube
Procedure.
Ratio = (avg. “test” net Abs.) / (avg. BSA net Abs.)
Protein Tested Ratio
Albumin, bovine serum 1.00
Aldolase, rabbit muscle 0.80
α-Chymotrypsinogen, bovine 0.99
Cytochrome C, horse heart 1.11
Gamma globulin, bovine 0.95
IgG, bovine 1.12
IgG, human 1.03
IgG, mouse 1.23
IgG, rabbit 1.12
IgG, sheep 1.14
Insulin, bovine pancreas 1.22
Myoglobin, horse heart 0.92
Ovalbumin 1.08
Transferrin, human 0.98
Average Ratio 1.05
Figure 1. Typical color response curves for BSA and BGG using the Test
Tube Procedure.
Standard Deviation 0.12
Coefficient of Variation 11.4%
Pierce Biotechnology PO Box 117 (815) 968-0747 www.thermo.com/pierce
3747 N. Meridian Road Rockford, lL 61105 USA (815) 968-7316 fax
4
Pierce Biotechnology PO Box 117 (815) 968-0747 www.thermo.com/pierce
3747 N. Meridian Road Rockford, lL 61105 USA (815) 968-7316 fax
5
D. Alternative Total Protein Assay Reagents
If interference by a reducing substance or metal-chelating substance contained in the sample cannot be overcome, try the
Coomassie Plus (Bradford) Protein Assay Kit (Product No. 23236), which is less sensitive to such substances.
E. Cleaning and Re-using Glassware
Care must be exercised when re-using glassware. The Micro BCA WR is sensitive to metal ions, especially copper ions. All
glassware must be cleaned and then given a thorough final rinse with ultrapure water.
Related Thermo Scientific Products
15041 Pierce 96-Well Plates, 100/pkg.
15075 Reagent Reservoirs, 200/pkg.
15036 Sealing Tape for 96-Well Plates, 100/pkg.
23209 Albumin Standard Ampules, 2 mg/ml, 10 × 1 ml ampules, containing bovine serum albumin (BSA)
23212 Bovine Gamma Globulin Standard, 2 mg/ml, 10 × 1 ml ampules, containing bovine gamma globulin
23236 Coomassie Plus (Bradford) Protein Assay Kit, working range 1-1,500 μg/ml
89882 Zeba™ Desalt Spin Columns, 0.5 ml, for desalting 20-130 µl samples
89889 Zeba Desalt Spin Columns, 2 ml, for desalting 200-700 µl samples
69576 Slide-A-Lyzer®
MINI Dialysis Units, 10 units and float for dialyzing 10-100 µl samples
69576 Slide-A-Lyzer Dialysis Cassettes, 10 units and floats for 100-500 µl samples
Cited References
1. Smith, P.K., et al. (1985). Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76-85.
2. Wiechelman, et al. (1988). Investigation of the bicinchoninic acid protein assay: Identification of the groups responsible for color formation. Anal
Biochem. 175:231-7.
3. Kessler, R. and Fanestil, D. (1986). Interference by lipids in the determination of protein using bicinchoninic acid. Anal. Biochem. 159:138-42.
4. Brown, R., et al. (1989). Protein measurement using bicinchoninic acid: elimination of interfering substances. Anal. Biochem. 180:136-9.
Product References
O'Nuallain, B. and Wetzel, R. (2002). Conformational Abs recognizing a generic amyloid fibril epitope. Proc. Natl. Acad. Sci. USA 99:1485-90.
Paratcha, G., et al. (2003). The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands. Cell 113:867-79.
Gembitsky, D.S., et al. (2004). A prototype antibody microarray platform to monitor changes in protein tyrosine phosphorylation. Mol. Cell. Proteomics
3:1102-1118.
Yang, G., et al. (2005). Activation-induced deaminase cloning, localization, and protein extraction from young Vh-mutant rabbit appendix. Proc. Natl. Acad.
Sci. USA 102:17083-8.
Slide-A-Lyzer®
Dialysis Cassette Technology is protected by U.S. Patent # 5,503,741 and 7,056,440.
Slide-A-Lyzer®
MINI Dialysis Unit Technology is protected by U.S. Patent # 6,039,871.
Triton®
is a registered trademark of Rohm & Haas Co.
Brij®
, Tween®
and Span®
are registered trademarks of ICI Americas.
Zwittergent®
is a registered trademark of American Hoechst Corporation.
This product (“Product”) is warranted to operate or perform substantially in conformance with published Product specifications in effect at the time of sale,
as set forth in the Product documentation, specifications and/or accompanying package inserts (“Documentation”) and to be free from defects in material and
workmanship. Unless otherwise expressly authorized in writing, Products are supplied for research use only. No claim of suitability for use in applications
regulated by FDA is made. The warranty provided herein is valid only when used by properly trained individuals. Unless otherwise stated in the
Documentation, this warranty is limited to one year from date of shipment when the Product is subjected to normal, proper and intended usage. This
warranty does not extend to anyone other than the original purchaser of the Product (“Buyer”).
No other warranties, express or implied, are granted, including without limitation, implied warranties of merchantability, fitness for any particular
purpose, or non infringement. Buyer’s exclusive remedy for non-conforming Products during the warranty period is limited to replacement of or
refund for the non-conforming Product(s).
There is no obligation to replace Products as the result of (i) accident, disaster or event of force majeure, (ii) misuse, fault or negligence of or by Buyer, (iii)
use of the Products in a manner for which they were not designed, or (iv) improper storage and handling of the Products.
Current versions of product instructions are available at www.thermo.com/pierce. For a faxed copy, call 800-874-3723 or contact your local distributor.
© 2008 Thermo Fisher Scientific Inc. All rights reserved. Unless otherwise indicated, all trademarks are property of Thermo Fisher Scientific Inc. and its
subsidiaries. Printed in the USA.
Pierce Biotechnology PO Box 117 (815) 968-0747 www.thermo.com/pierce
3747 N. Meridian Road Rockford, lL 61105 USA (815) 968-7316 fax
6
Table 2. Compatible Substance Concentrations in the Micro BCA Protein Assay (see text for details).
Substance
Compatible
Concentration
Salts/Buffers
ACES, pH 7.8 10 mM
Ammonium sulfate --------
Bicine, pH 8.4 2 mM
Bis-Tris, pH 6.5 0.2 mM
Borate (50 mM), pH 8.5 (#28384) 1:4 dilution*
B-PER
®
Reagent (#78248) 1:10 dilution*
Calcium chloride in TBS, pH 7.2 10 mM
Na-Carbonate/Na-Bicarbonate (0.2 M),
pH 9.4 (#28382)
undiluted
Cesium bicarbonate 100 mM
CHES, pH 9.0 100 mM
Na-Citrate (0.6 M), Na-Carbonate (0.1
M), pH 9.0 (#28388)
1:600 dilution*
Na-Citrate (0.6 M), MOPS (0.1 M), pH 7.5
(#28386)
1:600 dilution*
Cobalt chloride in TBS, pH 7.2 --------
EPPS, pH 8.0 100 mM
Ferric chloride in TBS, pH 7.2 0.5 mM
Glycine n/a
Guanidine•HCl 4 M
HEPES, pH 7.5 100 mM
Imidazole, pH 7.0 12.5 mM
MES, pH 6.1 100 mM
MES (0.1 M), NaCl (0.9%), pH 4.7 (#28390) 1:4 dilution*
MOPS, pH 7.2 100 mM
Modified Dulbecco’s PBS, pH 7.4 (#28374) undiluted
Nickel chloride in TBS, pH 7.2 0.2 mM
PBS; Phosphate (0.1 M), NaCl (0.15 M),
pH 7.2 (#28372)
undiluted
PIPES, pH 6.8 100 mM
RIPA lysis buffer; 50 mM Tris, 150 mM NaCl,
0.5% DOC, 1% NP-40, 0.1% SDS, pH 8.0
1:10 dilution*
Sodium acetate, pH 4.8 200 mM
Sodium azide 0.2%
Sodium bicarbonate 100 mM
Sodium chloride 1 M
Sodium citrate, pH 4.8 (or pH 6.4) 5 mM (16.7 mM)
Sodium phosphate 100 mM
Tricine, pH 8.0 2.5 mM
Triethanolamine, pH 7.8 0.5 mM
Tris 50 mM
TBS; Tris (25 mM), NaCl (0.15 M), pH 7.6
(#28376)
1:10 dilution*
Tris (25 mM), Glycine (192 mM), pH 8.0
(#28380)
1:10 dilution*
Tris (25 mM), Glycine (192 mM), SDS
(0.1%), pH 8.3 (#28378)
undiluted
Zinc chloride in TBS, pH 7.2 0.5 mM
Substance
Compatible
Concentration
Detergents**
Brij
®
-35 5.0%
Brij-56, Brij-58 1.0%
CHAPS (CHAPSO) 1.0% (5.0%)
Deoxycholic acid 5.0%
Nonidet P-40 (NP-40) 5.0%
Octyl β-glucoside 0.1%
Octyl β-thioglucopyranoside 5.0%
SDS 5.0%
Span
®
20 1.0%
Triton
®
X-100 5.0%
Triton X-114 0.05%
Triton X-305, X-405 1.0%
Tween
®
-20, Tween-80 5.0%
Tween-60 0.5%
Zwittergent
®
3-14 --------
Chelating agents
EDTA 0.5 mM
EGTA --------
Sodium citrate, pH 4.8 (or pH 6.4) 5 mM (16.7 mM)
Reducing & Thiol-Containing Agents
N-acetylglucosamine in PBS, pH 7.2 --------
Ascorbic acid --------
Cysteine --------
Dithioerythritol (DTE) --------
Dithiothreitol (DTT) --------
Glucose 1 mM
2-Mercaptoethanol 1 mM
Thimerosal --------
Misc. Reagents & Solvents
Acetone 1.0%
Acetonitrile 1.0%
Aprotinin 1 mg/L
DMF, DMSO 1.0%
Ethanol 1.0%
Glycerol (Fresh) 1.0%
Hydrazide --------
Hydrides (Na2BH4 or NaCNBH3) --------
Hydrochloric Acid 10 mM
Leupeptin 10 mg/L
Methanol 1.0%
Phenol Red --------
PMSF 1 mM
Sodium Hydroxide 50 mM
Sucrose 4%
TLCK 0.1 mg/L
TPCK 0.1 mg/L
Urea 3 M
o-Vanadate (sodium salt), in PBS, pH 7.2 1 mM
* Diluted with ultrapure water
** Detergents were tested using Pierce high-purity Surfact-Amps
®
Products, which have low peroxide content
--- Dashed-line entry indicates that the material is incompatible with the assay

Mais conteúdo relacionado

Mais procurados

Mais procurados (20)

Micro RNA.ppt
Micro RNA.pptMicro RNA.ppt
Micro RNA.ppt
 
Micro RNA biogenesis, function and nomenclature
Micro RNA biogenesis, function and nomenclatureMicro RNA biogenesis, function and nomenclature
Micro RNA biogenesis, function and nomenclature
 
Synthetic lethality and cancer
Synthetic lethality and cancer Synthetic lethality and cancer
Synthetic lethality and cancer
 
mi RNA regulation
mi RNA regulationmi RNA regulation
mi RNA regulation
 
Mirnas
MirnasMirnas
Mirnas
 
Mirna and its applications
Mirna and its applicationsMirna and its applications
Mirna and its applications
 
miRNA - Biogenesis, Function and Regulation
miRNA - Biogenesis, Function and RegulationmiRNA - Biogenesis, Function and Regulation
miRNA - Biogenesis, Function and Regulation
 
Dna microarray
Dna microarrayDna microarray
Dna microarray
 
TYPES OF RNA.pptx
TYPES OF RNA.pptxTYPES OF RNA.pptx
TYPES OF RNA.pptx
 
Organization and expression of immunoglobulin genes
Organization and expression of immunoglobulin genesOrganization and expression of immunoglobulin genes
Organization and expression of immunoglobulin genes
 
microRNA for Clinical Research and Tumor Analysis
microRNA for Clinical Research and Tumor AnalysismicroRNA for Clinical Research and Tumor Analysis
microRNA for Clinical Research and Tumor Analysis
 
Functions of micro RNA
Functions of micro RNAFunctions of micro RNA
Functions of micro RNA
 
LncRNA (Long noncoding RNA)
LncRNA (Long noncoding RNA)LncRNA (Long noncoding RNA)
LncRNA (Long noncoding RNA)
 
Micro rna
Micro rnaMicro rna
Micro rna
 
SiRNA
SiRNASiRNA
SiRNA
 
Role of micro rna in oncogenesis
Role of micro rna in oncogenesisRole of micro rna in oncogenesis
Role of micro rna in oncogenesis
 
Lesson- Jihad
Lesson- JihadLesson- Jihad
Lesson- Jihad
 
non coding RNA
non coding RNAnon coding RNA
non coding RNA
 
MHC and Ig.pptx
MHC and Ig.pptxMHC and Ig.pptx
MHC and Ig.pptx
 
Rna i[2]
Rna i[2]Rna i[2]
Rna i[2]
 

Destaque

ICSA32 - Antigen discovery
ICSA32 - Antigen discoveryICSA32 - Antigen discovery
ICSA32 - Antigen discoveryRicardo Portela
 
ICSA17 Imunologia - Manual eletroforese
ICSA17 Imunologia - Manual eletroforeseICSA17 Imunologia - Manual eletroforese
ICSA17 Imunologia - Manual eletroforeseRicardo Portela
 
ICSA17 - Resposta Imune a infecções
ICSA17 - Resposta Imune a infecçõesICSA17 - Resposta Imune a infecções
ICSA17 - Resposta Imune a infecçõesRicardo Portela
 
ICSA17 - Imunologia - Manual kit tr dpp sifilis hiv
ICSA17 - Imunologia - Manual kit tr dpp sifilis hivICSA17 - Imunologia - Manual kit tr dpp sifilis hiv
ICSA17 - Imunologia - Manual kit tr dpp sifilis hivRicardo Portela
 
ICSA17 - Hipersensibilidades
ICSA17 - HipersensibilidadesICSA17 - Hipersensibilidades
ICSA17 - HipersensibilidadesRicardo Portela
 
ICSA17 - Resposta Imune a infecções PDF
ICSA17 - Resposta Imune a infecções PDFICSA17 - Resposta Imune a infecções PDF
ICSA17 - Resposta Imune a infecções PDFRicardo Portela
 
ICSA32 - Produção e controle qualidade vacinas
ICSA32 - Produção e controle qualidade vacinasICSA32 - Produção e controle qualidade vacinas
ICSA32 - Produção e controle qualidade vacinasRicardo Portela
 
ICSC48 - Histórico do bioterismo
ICSC48 - Histórico do bioterismoICSC48 - Histórico do bioterismo
ICSC48 - Histórico do bioterismoRicardo Portela
 
ICSC48 - Criação e manejo de primatas não humanos e cães
ICSC48 - Criação e manejo de primatas não humanos e cãesICSC48 - Criação e manejo de primatas não humanos e cães
ICSC48 - Criação e manejo de primatas não humanos e cãesRicardo Portela
 
ICSA06 - Biotecnologia e saúde humana
ICSA06 - Biotecnologia e saúde humanaICSA06 - Biotecnologia e saúde humana
ICSA06 - Biotecnologia e saúde humanaRicardo Portela
 
ICSA17 - Imunidade inata
ICSA17 - Imunidade inataICSA17 - Imunidade inata
ICSA17 - Imunidade inataRicardo Portela
 
ICSA32 - História da vacinologia
ICSA32 - História da vacinologiaICSA32 - História da vacinologia
ICSA32 - História da vacinologiaRicardo Portela
 
ICSC48 - Classificação dos animais de laboratório quanto ao status genético
ICSC48 - Classificação dos animais de laboratório quanto ao status genéticoICSC48 - Classificação dos animais de laboratório quanto ao status genético
ICSC48 - Classificação dos animais de laboratório quanto ao status genéticoRicardo Portela
 
ICSA17 - Mecanismos efetores da RI Celular
ICSA17 - Mecanismos efetores da RI CelularICSA17 - Mecanismos efetores da RI Celular
ICSA17 - Mecanismos efetores da RI CelularRicardo Portela
 
ICSA17 - Eletroforese em gel de acrilamida
ICSA17 - Eletroforese em gel de acrilamidaICSA17 - Eletroforese em gel de acrilamida
ICSA17 - Eletroforese em gel de acrilamidaRicardo Portela
 
ICSC48 - Criação e manejo de coelhos
ICSC48 - Criação e manejo de coelhosICSC48 - Criação e manejo de coelhos
ICSC48 - Criação e manejo de coelhosRicardo Portela
 
ICSA17 - Fundamentos e Tipos de Vacinas
ICSA17 - Fundamentos e Tipos de VacinasICSA17 - Fundamentos e Tipos de Vacinas
ICSA17 - Fundamentos e Tipos de VacinasRicardo Portela
 

Destaque (20)

ICSA32 - Antigen discovery
ICSA32 - Antigen discoveryICSA32 - Antigen discovery
ICSA32 - Antigen discovery
 
ICSA17 Imunologia - Manual eletroforese
ICSA17 Imunologia - Manual eletroforeseICSA17 Imunologia - Manual eletroforese
ICSA17 Imunologia - Manual eletroforese
 
ICSA17 - Resposta Imune a infecções
ICSA17 - Resposta Imune a infecçõesICSA17 - Resposta Imune a infecções
ICSA17 - Resposta Imune a infecções
 
ICSA17 - Imunologia - Manual kit tr dpp sifilis hiv
ICSA17 - Imunologia - Manual kit tr dpp sifilis hivICSA17 - Imunologia - Manual kit tr dpp sifilis hiv
ICSA17 - Imunologia - Manual kit tr dpp sifilis hiv
 
ICSA17 - Hipersensibilidades
ICSA17 - HipersensibilidadesICSA17 - Hipersensibilidades
ICSA17 - Hipersensibilidades
 
ICSA17 - Autoimunidade
ICSA17 - Autoimunidade ICSA17 - Autoimunidade
ICSA17 - Autoimunidade
 
ICSA17 - Resposta Imune a infecções PDF
ICSA17 - Resposta Imune a infecções PDFICSA17 - Resposta Imune a infecções PDF
ICSA17 - Resposta Imune a infecções PDF
 
ICSA32 - Produção e controle qualidade vacinas
ICSA32 - Produção e controle qualidade vacinasICSA32 - Produção e controle qualidade vacinas
ICSA32 - Produção e controle qualidade vacinas
 
ICSA17 - Imunoterapia
ICSA17 - ImunoterapiaICSA17 - Imunoterapia
ICSA17 - Imunoterapia
 
ICSC48 - Histórico do bioterismo
ICSC48 - Histórico do bioterismoICSC48 - Histórico do bioterismo
ICSC48 - Histórico do bioterismo
 
ICSC48 - Criação e manejo de primatas não humanos e cães
ICSC48 - Criação e manejo de primatas não humanos e cãesICSC48 - Criação e manejo de primatas não humanos e cães
ICSC48 - Criação e manejo de primatas não humanos e cães
 
ICSA06 - Biotecnologia e saúde humana
ICSA06 - Biotecnologia e saúde humanaICSA06 - Biotecnologia e saúde humana
ICSA06 - Biotecnologia e saúde humana
 
ICSA17 - Imunidade inata
ICSA17 - Imunidade inataICSA17 - Imunidade inata
ICSA17 - Imunidade inata
 
ICSA32 - História da vacinologia
ICSA32 - História da vacinologiaICSA32 - História da vacinologia
ICSA32 - História da vacinologia
 
ICSC48 - Classificação dos animais de laboratório quanto ao status genético
ICSC48 - Classificação dos animais de laboratório quanto ao status genéticoICSC48 - Classificação dos animais de laboratório quanto ao status genético
ICSC48 - Classificação dos animais de laboratório quanto ao status genético
 
ICSA17 - Mecanismos efetores da RI Celular
ICSA17 - Mecanismos efetores da RI CelularICSA17 - Mecanismos efetores da RI Celular
ICSA17 - Mecanismos efetores da RI Celular
 
ICSA17 - Eletroforese em gel de acrilamida
ICSA17 - Eletroforese em gel de acrilamidaICSA17 - Eletroforese em gel de acrilamida
ICSA17 - Eletroforese em gel de acrilamida
 
ICSC48 - Criação e manejo de coelhos
ICSC48 - Criação e manejo de coelhosICSC48 - Criação e manejo de coelhos
ICSC48 - Criação e manejo de coelhos
 
ICSA17 - Tolerância
ICSA17 - TolerânciaICSA17 - Tolerância
ICSA17 - Tolerância
 
ICSA17 - Fundamentos e Tipos de Vacinas
ICSA17 - Fundamentos e Tipos de VacinasICSA17 - Fundamentos e Tipos de Vacinas
ICSA17 - Fundamentos e Tipos de Vacinas
 

Semelhante a ICSA17 - Bula Dosagem Proteínas

Western blotting protocol & troubleshooting
Western blotting protocol & troubleshootingWestern blotting protocol & troubleshooting
Western blotting protocol & troubleshootingJames Waita
 
Protein quantitation techniques
Protein quantitation techniquesProtein quantitation techniques
Protein quantitation techniquesGirish Kumar K
 
Final submission –Pay attention to APA formatting, spelling, and
Final submission –Pay attention to APA formatting, spelling, andFinal submission –Pay attention to APA formatting, spelling, and
Final submission –Pay attention to APA formatting, spelling, andChereCheek752
 
The Determination of Total Protein Using the LAMBDA UV/Vis Spectrophotometer:...
The Determination of Total Protein Using the LAMBDA UV/Vis Spectrophotometer:...The Determination of Total Protein Using the LAMBDA UV/Vis Spectrophotometer:...
The Determination of Total Protein Using the LAMBDA UV/Vis Spectrophotometer:...PerkinElmer, Inc.
 
Lab1 spectrophotometry
Lab1 spectrophotometryLab1 spectrophotometry
Lab1 spectrophotometryCody Taylor
 
Biochemistry and molecular biology lab MANIK
Biochemistry and molecular biology lab MANIKBiochemistry and molecular biology lab MANIK
Biochemistry and molecular biology lab MANIKImran Nur Manik
 
Practical 3 Quantitative determination of protein concentration using spectro...
Practical 3 Quantitative determination of protein concentration using spectro...Practical 3 Quantitative determination of protein concentration using spectro...
Practical 3 Quantitative determination of protein concentration using spectro...mohamedseyam13
 
Chemical Oxygen Demand
Chemical Oxygen DemandChemical Oxygen Demand
Chemical Oxygen DemandMuhd Effandi
 
Analysis of Quaternary Ammonium Compounds (QACs) as Possible Disinfectant Res...
Analysis of Quaternary Ammonium Compounds (QACs) as Possible Disinfectant Res...Analysis of Quaternary Ammonium Compounds (QACs) as Possible Disinfectant Res...
Analysis of Quaternary Ammonium Compounds (QACs) as Possible Disinfectant Res...PerkinElmer, Inc.
 
IntroductionIn terms of total production tonnages used f.docx
IntroductionIn terms of total production tonnages used f.docxIntroductionIn terms of total production tonnages used f.docx
IntroductionIn terms of total production tonnages used f.docxvrickens
 
Micro assay dr. saisivam (04-03-2016)
Micro assay   dr. saisivam (04-03-2016)Micro assay   dr. saisivam (04-03-2016)
Micro assay dr. saisivam (04-03-2016)Saisivam Srinivasan
 
An083 121102 549-2 - diquat & paraquat - smart_prep
An083 121102   549-2 - diquat  & paraquat - smart_prepAn083 121102   549-2 - diquat  & paraquat - smart_prep
An083 121102 549-2 - diquat & paraquat - smart_prepPaola Tapia Avila
 
Molecular biology (Practical) MANIK
Molecular biology (Practical) MANIKMolecular biology (Practical) MANIK
Molecular biology (Practical) MANIKImran Nur Manik
 

Semelhante a ICSA17 - Bula Dosagem Proteínas (20)

Western blotting protocol & troubleshooting
Western blotting protocol & troubleshootingWestern blotting protocol & troubleshooting
Western blotting protocol & troubleshooting
 
Western Blotting Protocol & Troubleshooting
Western Blotting Protocol & TroubleshootingWestern Blotting Protocol & Troubleshooting
Western Blotting Protocol & Troubleshooting
 
Protein quantitation techniques
Protein quantitation techniquesProtein quantitation techniques
Protein quantitation techniques
 
Final submission –Pay attention to APA formatting, spelling, and
Final submission –Pay attention to APA formatting, spelling, andFinal submission –Pay attention to APA formatting, spelling, and
Final submission –Pay attention to APA formatting, spelling, and
 
Quantitative test for Protein by Bradford Assay.pptx
Quantitative test for Protein by Bradford Assay.pptxQuantitative test for Protein by Bradford Assay.pptx
Quantitative test for Protein by Bradford Assay.pptx
 
The Determination of Total Protein Using the LAMBDA UV/Vis Spectrophotometer:...
The Determination of Total Protein Using the LAMBDA UV/Vis Spectrophotometer:...The Determination of Total Protein Using the LAMBDA UV/Vis Spectrophotometer:...
The Determination of Total Protein Using the LAMBDA UV/Vis Spectrophotometer:...
 
Lab1 spectrophotometry
Lab1 spectrophotometryLab1 spectrophotometry
Lab1 spectrophotometry
 
Biochemistry and molecular biology lab MANIK
Biochemistry and molecular biology lab MANIKBiochemistry and molecular biology lab MANIK
Biochemistry and molecular biology lab MANIK
 
Practical 3 got
Practical 3 gotPractical 3 got
Practical 3 got
 
Practical 3 Quantitative determination of protein concentration using spectro...
Practical 3 Quantitative determination of protein concentration using spectro...Practical 3 Quantitative determination of protein concentration using spectro...
Practical 3 Quantitative determination of protein concentration using spectro...
 
Bulletin 6376 (2)
Bulletin 6376 (2)Bulletin 6376 (2)
Bulletin 6376 (2)
 
Chemical Oxygen Demand
Chemical Oxygen DemandChemical Oxygen Demand
Chemical Oxygen Demand
 
Analysis of Quaternary Ammonium Compounds (QACs) as Possible Disinfectant Res...
Analysis of Quaternary Ammonium Compounds (QACs) as Possible Disinfectant Res...Analysis of Quaternary Ammonium Compounds (QACs) as Possible Disinfectant Res...
Analysis of Quaternary Ammonium Compounds (QACs) as Possible Disinfectant Res...
 
IntroductionIn terms of total production tonnages used f.docx
IntroductionIn terms of total production tonnages used f.docxIntroductionIn terms of total production tonnages used f.docx
IntroductionIn terms of total production tonnages used f.docx
 
Micro assay dr. saisivam (04-03-2016)
Micro assay   dr. saisivam (04-03-2016)Micro assay   dr. saisivam (04-03-2016)
Micro assay dr. saisivam (04-03-2016)
 
Paraquat
ParaquatParaquat
Paraquat
 
An083 121102 549-2 - diquat & paraquat - smart_prep
An083 121102   549-2 - diquat  & paraquat - smart_prepAn083 121102   549-2 - diquat  & paraquat - smart_prep
An083 121102 549-2 - diquat & paraquat - smart_prep
 
Molecular biology (Practical) MANIK
Molecular biology (Practical) MANIKMolecular biology (Practical) MANIK
Molecular biology (Practical) MANIK
 
Stages of Production of Escozine For Pets™
Stages of Production of Escozine For Pets™ Stages of Production of Escozine For Pets™
Stages of Production of Escozine For Pets™
 
JJSA
JJSAJJSA
JJSA
 

Mais de Ricardo Portela

ICSA29 Imunodiagnostico - Criterios de validacao
ICSA29 Imunodiagnostico - Criterios de validacaoICSA29 Imunodiagnostico - Criterios de validacao
ICSA29 Imunodiagnostico - Criterios de validacaoRicardo Portela
 
3 ways to make the research writing process easier
3 ways to make the research writing process easier3 ways to make the research writing process easier
3 ways to make the research writing process easierRicardo Portela
 
ICSA32 - Antigen Discovery
ICSA32 - Antigen DiscoveryICSA32 - Antigen Discovery
ICSA32 - Antigen DiscoveryRicardo Portela
 
ICSA17 Imunologia (Prática) - Anticorpos monoclonais
ICSA17 Imunologia (Prática) - Anticorpos monoclonaisICSA17 Imunologia (Prática) - Anticorpos monoclonais
ICSA17 Imunologia (Prática) - Anticorpos monoclonaisRicardo Portela
 
ICSA17 Imunologia (Prática) - Imunoprecipitação
ICSA17 Imunologia (Prática) - ImunoprecipitaçãoICSA17 Imunologia (Prática) - Imunoprecipitação
ICSA17 Imunologia (Prática) - ImunoprecipitaçãoRicardo Portela
 
ICSA17 Imunologia (Prática) - Imunoaglutinação
ICSA17 Imunologia (Prática) - ImunoaglutinaçãoICSA17 Imunologia (Prática) - Imunoaglutinação
ICSA17 Imunologia (Prática) - ImunoaglutinaçãoRicardo Portela
 
ICSA17 Imunologia (Prática) - Imunofluorescencia
ICSA17 Imunologia (Prática) - ImunofluorescenciaICSA17 Imunologia (Prática) - Imunofluorescencia
ICSA17 Imunologia (Prática) - ImunofluorescenciaRicardo Portela
 
ICSA17 Imunologia (Prática) - Citometria de fluxo
ICSA17 Imunologia (Prática) - Citometria de fluxoICSA17 Imunologia (Prática) - Citometria de fluxo
ICSA17 Imunologia (Prática) - Citometria de fluxoRicardo Portela
 
ICSA17 Imunologia (Prática) - ELISA
ICSA17 Imunologia (Prática) - ELISAICSA17 Imunologia (Prática) - ELISA
ICSA17 Imunologia (Prática) - ELISARicardo Portela
 
ICSA17 Imunologia (Prática) - Identificação de leucócitos
ICSA17 Imunologia (Prática) - Identificação de leucócitosICSA17 Imunologia (Prática) - Identificação de leucócitos
ICSA17 Imunologia (Prática) - Identificação de leucócitosRicardo Portela
 
ICSA17 Imunologia (Prática) - Imunocromatografia
ICSA17 Imunologia (Prática) - ImunocromatografiaICSA17 Imunologia (Prática) - Imunocromatografia
ICSA17 Imunologia (Prática) - ImunocromatografiaRicardo Portela
 
ICSA17 Imunologia (Prática) - Critérios de validação de ensaios de diagnóstico
ICSA17 Imunologia (Prática) - Critérios de validação de ensaios de diagnóstico ICSA17 Imunologia (Prática) - Critérios de validação de ensaios de diagnóstico
ICSA17 Imunologia (Prática) - Critérios de validação de ensaios de diagnóstico Ricardo Portela
 
ICSC48 - Criação e manejo de cobaias
ICSC48 - Criação e manejo de cobaiasICSC48 - Criação e manejo de cobaias
ICSC48 - Criação e manejo de cobaiasRicardo Portela
 
ICSC48 - Criação e manejo de camundongos e ratos
ICSC48 - Criação e manejo de camundongos e ratosICSC48 - Criação e manejo de camundongos e ratos
ICSC48 - Criação e manejo de camundongos e ratosRicardo Portela
 
ICSC48 - Classificação dos biotérios
ICSC48 - Classificação dos biotériosICSC48 - Classificação dos biotérios
ICSC48 - Classificação dos biotériosRicardo Portela
 
ICSC48 - Classificação dos animais de laboratório quanto ao status sanitário
ICSC48 - Classificação dos animais de laboratório quanto ao status sanitárioICSC48 - Classificação dos animais de laboratório quanto ao status sanitário
ICSC48 - Classificação dos animais de laboratório quanto ao status sanitárioRicardo Portela
 
ICSC48 - Aspectos éticos na experimentação animal
ICSC48 - Aspectos éticos na experimentação animalICSC48 - Aspectos éticos na experimentação animal
ICSC48 - Aspectos éticos na experimentação animalRicardo Portela
 

Mais de Ricardo Portela (18)

ICSA29 Imunodiagnostico - Criterios de validacao
ICSA29 Imunodiagnostico - Criterios de validacaoICSA29 Imunodiagnostico - Criterios de validacao
ICSA29 Imunodiagnostico - Criterios de validacao
 
3 ways to make the research writing process easier
3 ways to make the research writing process easier3 ways to make the research writing process easier
3 ways to make the research writing process easier
 
Twenty one suggestions
Twenty one suggestionsTwenty one suggestions
Twenty one suggestions
 
ICSA32 - Antigen Discovery
ICSA32 - Antigen DiscoveryICSA32 - Antigen Discovery
ICSA32 - Antigen Discovery
 
ICSA17 Imunologia (Prática) - Anticorpos monoclonais
ICSA17 Imunologia (Prática) - Anticorpos monoclonaisICSA17 Imunologia (Prática) - Anticorpos monoclonais
ICSA17 Imunologia (Prática) - Anticorpos monoclonais
 
ICSA17 Imunologia (Prática) - Imunoprecipitação
ICSA17 Imunologia (Prática) - ImunoprecipitaçãoICSA17 Imunologia (Prática) - Imunoprecipitação
ICSA17 Imunologia (Prática) - Imunoprecipitação
 
ICSA17 Imunologia (Prática) - Imunoaglutinação
ICSA17 Imunologia (Prática) - ImunoaglutinaçãoICSA17 Imunologia (Prática) - Imunoaglutinação
ICSA17 Imunologia (Prática) - Imunoaglutinação
 
ICSA17 Imunologia (Prática) - Imunofluorescencia
ICSA17 Imunologia (Prática) - ImunofluorescenciaICSA17 Imunologia (Prática) - Imunofluorescencia
ICSA17 Imunologia (Prática) - Imunofluorescencia
 
ICSA17 Imunologia (Prática) - Citometria de fluxo
ICSA17 Imunologia (Prática) - Citometria de fluxoICSA17 Imunologia (Prática) - Citometria de fluxo
ICSA17 Imunologia (Prática) - Citometria de fluxo
 
ICSA17 Imunologia (Prática) - ELISA
ICSA17 Imunologia (Prática) - ELISAICSA17 Imunologia (Prática) - ELISA
ICSA17 Imunologia (Prática) - ELISA
 
ICSA17 Imunologia (Prática) - Identificação de leucócitos
ICSA17 Imunologia (Prática) - Identificação de leucócitosICSA17 Imunologia (Prática) - Identificação de leucócitos
ICSA17 Imunologia (Prática) - Identificação de leucócitos
 
ICSA17 Imunologia (Prática) - Imunocromatografia
ICSA17 Imunologia (Prática) - ImunocromatografiaICSA17 Imunologia (Prática) - Imunocromatografia
ICSA17 Imunologia (Prática) - Imunocromatografia
 
ICSA17 Imunologia (Prática) - Critérios de validação de ensaios de diagnóstico
ICSA17 Imunologia (Prática) - Critérios de validação de ensaios de diagnóstico ICSA17 Imunologia (Prática) - Critérios de validação de ensaios de diagnóstico
ICSA17 Imunologia (Prática) - Critérios de validação de ensaios de diagnóstico
 
ICSC48 - Criação e manejo de cobaias
ICSC48 - Criação e manejo de cobaiasICSC48 - Criação e manejo de cobaias
ICSC48 - Criação e manejo de cobaias
 
ICSC48 - Criação e manejo de camundongos e ratos
ICSC48 - Criação e manejo de camundongos e ratosICSC48 - Criação e manejo de camundongos e ratos
ICSC48 - Criação e manejo de camundongos e ratos
 
ICSC48 - Classificação dos biotérios
ICSC48 - Classificação dos biotériosICSC48 - Classificação dos biotérios
ICSC48 - Classificação dos biotérios
 
ICSC48 - Classificação dos animais de laboratório quanto ao status sanitário
ICSC48 - Classificação dos animais de laboratório quanto ao status sanitárioICSC48 - Classificação dos animais de laboratório quanto ao status sanitário
ICSC48 - Classificação dos animais de laboratório quanto ao status sanitário
 
ICSC48 - Aspectos éticos na experimentação animal
ICSC48 - Aspectos éticos na experimentação animalICSC48 - Aspectos éticos na experimentação animal
ICSC48 - Aspectos éticos na experimentação animal
 

Último

Man or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptx
Man or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptxMan or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptx
Man or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptxDhatriParmar
 
Measures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataMeasures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataBabyAnnMotar
 
Mythology Quiz-4th April 2024, Quiz Club NITW
Mythology Quiz-4th April 2024, Quiz Club NITWMythology Quiz-4th April 2024, Quiz Club NITW
Mythology Quiz-4th April 2024, Quiz Club NITWQuiz Club NITW
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxVanesaIglesias10
 
ClimART Action | eTwinning Project
ClimART Action    |    eTwinning ProjectClimART Action    |    eTwinning Project
ClimART Action | eTwinning Projectjordimapav
 
Oppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and FilmOppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and FilmStan Meyer
 
How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17Celine George
 
Concurrency Control in Database Management system
Concurrency Control in Database Management systemConcurrency Control in Database Management system
Concurrency Control in Database Management systemChristalin Nelson
 
Multi Domain Alias In the Odoo 17 ERP Module
Multi Domain Alias In the Odoo 17 ERP ModuleMulti Domain Alias In the Odoo 17 ERP Module
Multi Domain Alias In the Odoo 17 ERP ModuleCeline George
 
Narcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfNarcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfPrerana Jadhav
 
Congestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationCongestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationdeepaannamalai16
 
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...Association for Project Management
 
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvRicaMaeCastro1
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4JOYLYNSAMANIEGO
 
How to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseHow to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseCeline George
 
Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Seán Kennedy
 
Grade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptxGrade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptxkarenfajardo43
 

Último (20)

Man or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptx
Man or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptxMan or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptx
Man or Manufactured_ Redefining Humanity Through Biopunk Narratives.pptx
 
Measures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataMeasures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped data
 
prashanth updated resume 2024 for Teaching Profession
prashanth updated resume 2024 for Teaching Professionprashanth updated resume 2024 for Teaching Profession
prashanth updated resume 2024 for Teaching Profession
 
Mythology Quiz-4th April 2024, Quiz Club NITW
Mythology Quiz-4th April 2024, Quiz Club NITWMythology Quiz-4th April 2024, Quiz Club NITW
Mythology Quiz-4th April 2024, Quiz Club NITW
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptx
 
ClimART Action | eTwinning Project
ClimART Action    |    eTwinning ProjectClimART Action    |    eTwinning Project
ClimART Action | eTwinning Project
 
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptxINCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
 
Oppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and FilmOppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and Film
 
How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17
 
Paradigm shift in nursing research by RS MEHTA
Paradigm shift in nursing research by RS MEHTAParadigm shift in nursing research by RS MEHTA
Paradigm shift in nursing research by RS MEHTA
 
Concurrency Control in Database Management system
Concurrency Control in Database Management systemConcurrency Control in Database Management system
Concurrency Control in Database Management system
 
Multi Domain Alias In the Odoo 17 ERP Module
Multi Domain Alias In the Odoo 17 ERP ModuleMulti Domain Alias In the Odoo 17 ERP Module
Multi Domain Alias In the Odoo 17 ERP Module
 
Narcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfNarcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdf
 
Congestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationCongestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentation
 
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
Team Lead Succeed – Helping you and your team achieve high-performance teamwo...
 
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4
 
How to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseHow to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 Database
 
Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...
 
Grade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptxGrade Three -ELLNA-REVIEWER-ENGLISH.pptx
Grade Three -ELLNA-REVIEWER-ENGLISH.pptx
 

ICSA17 - Bula Dosagem Proteínas

  • 1. INSTRUCTIONS 0412.423235 Micro BCA™ Protein Assay Kit Number Description 23235 Micro BCA Protein Assay Kit, sufficient reagents for 480 tube assays or 3,200 microplate assays Kit Contents: Micro BCA Reagent A (MA), 240 ml Micro BCA Reagent B (MB), 240 ml Micro BCA Reagent C (MC), 12 ml Albumin Standard Ampules, 2 mg/ml, 10 × 1 ml ampules containing bovine serum albumin (BSA) at 2.0 mg/ml in a solution of 0.9% saline and 0.05% sodium azide Storage: Upon receipt store product at room temperature. Product shipped at ambient temperature. Note: If either Reagent MA or Reagent MB precipitates upon shipping in cold weather or during long- term storage, dissolve precipitates by gently warming and stirring solutions. Discard any reagent that shows discoloration or evidence of microbial contamination. Table of Contents Introduction .................................................................................................................................................................................1 Preparation of Standards and Working Reagent..........................................................................................................................2 Test Tube Procedure (linear working range of 0.5-20 µg/ml) .....................................................................................................3 Microplate Procedure (linear working range of 2-40 µg/ml).......................................................................................................3 Troubleshooting...........................................................................................................................................................................3 Additional Information ................................................................................................................................................................4 Related Products..........................................................................................................................................................................5 References ...................................................................................................................................................................................5 Introduction The Thermo Scientific Micro BCA Protein Assay Kit is a detergent-compatible bicinchoninic acid formulation for the colorimetric detection and quantitation of total protein. An adaptation of the Thermo Scientific Pierce BCA Protein Assay Kit (Product No. 23225), the Micro BCA Kit has been optimized for use with dilute protein samples (0.5-20 μg/ml). The unique, patented method utilizes bicinchoninic acid (BCA) as the detection reagent for Cu+1 , which is formed when Cu+2 is reduced by protein in an alkaline environment.1 A purple-colored reaction product is formed by the chelation of two molecules of BCA with one cuprous ion (Cu+1 ). This water-soluble complex exhibits a strong absorbance at 562 nm that is linear with increasing protein concentrations. The macromolecular structure of protein, the number of peptide bonds and the presence of four amino acids (cysteine, cystine, tryptophan and tyrosine) are reported to be responsible for color formation with BCA.2 Studies with di-, tri- and tetrapeptides suggest that the extent of color formation is caused by more than the mere sum of individual color-producing functional groups.2 The Micro BCA Protein Assay Kit uses concentrated reagents and a protocol that utilizes an extended incubation time at an elevated temperature (60°C, Test Tube Procedure only). The result is an extremely sensitive colorimetric protein assay in a test tube or microplate assay format. Pierce Biotechnology PO Box 117 (815) 968-0747 www.thermo.com/pierce 3747 N. Meridian Road Rockford, lL 61105 USA (815) 968-7316 fax
  • 2. Preparation of Standards and Working Reagent A. Preparation of Diluted Albumin (BSA) Standards Use Table 1 as a guide to prepare a set of protein standards. Dilute the contents of one Albumin (BSA) Standard ampule into several clean vials, preferably using a diluent that is similar to the sample buffer. Each 1 ml ampule of 2.0 mg/ml Albumin Standard is sufficient to prepare a set of diluted standards such that three replicates of each dilution may be included in the Test Tube Procedure. Table 1. Preparation of Diluted Albumin (BSA) Standards Vial Volume of Diluent Volume and Source of BSA Final BSA Concentration A 4.5 ml 0.5 ml of Stock 200 μg/ml B 8.0 ml 2.0 ml of vial A dilution 40 μg/ml C 4.0 ml 4.0 ml of vial B dilution 20 μg/ml D 4.0 ml 4.0 ml of vial C dilution 10 μg/ml E 4.0 ml 4.0 ml of vial D dilution 5 μg/ml F 4.0 ml 4.0 ml of vial E dilution 2.5 μg/ml G 4.8 ml 3.2 ml of vial F dilution 1 μg/ml H 4.0 ml 4.0 ml of vial G dilution 0.5 μg/ml I 8.0 ml 0 0 μg/ml = Blank B. Preparation of the Micro BCA Working Reagent (WR) 1. Use the following formula to determine the total volume of WR required: (# standards + # unknowns) × (# replicates) × (volume of WR per sample) = total volume WR required Example: for the standard Test Tube Procedure with 3 unknowns and 2 replicates of each sample: (9 standards + 3 unknowns) × (2 replicates) × (1 ml) = 24 ml WR required (round up to 25 ml) Note: 1 ml of the WR is required for each sample in the Test Tube Procedure, while only 150 µl of WR is required for each sample in the Microplate Procedure. 2. Prepare WR by mixing 25 parts of Micro BCA Reagent MA and 24 parts Reagent MB with 1 part of Reagent MC (25:24:1, Reagent MA:MB:MC). For the above example, combine 12.5 ml of Reagent MA and 12.0 ml Reagent MB with 0.5 ml of Reagent MC. Note: When Reagent MC is initially added to Reagents MA and MB, turbidity occurs that quickly disappears upon mixing to yield a clear-green solution. Prepare sufficient volume of WR based on the number of samples to be assayed. The WR is stable for one day when stored in a closed container at room temperature (RT). It is not necessary to protect the solution from light. Procedure Summary (Test Tube Procedure) Pierce Biotechnology PO Box 117 (815) 968-0747 www.thermo.com/pierce 3747 N. Meridian Road Rockford, lL 61105 USA (815) 968-7316 fax 2
  • 3. Pierce Biotechnology PO Box 117 (815) 968-0747 www.thermo.com/pierce 3747 N. Meridian Road Rockford, lL 61105 USA (815) 968-7316 fax 3 Test Tube Procedure (linear working range of 0.5-20 µg/ml) 1. Pipette 1.0 ml of each standard and unknown sample replicate into appropriately labeled test tubes. 2. Add 1.0 ml of the WR to each tube and mix well. 3. Cover tubes and incubate at 60°C in a water bath for 1 hour. 4. Cool all tubes to room temperature (RT). 5. With the spectrophotometer set to 562 nm, zero the instrument on a cuvette filled only with water. Subsequently, measure the absorbance of all the samples within 10 minutes. Note: Color development continues even after cooling to RT. However, the rate of development at RT is sufficient low that no significant error is introduced if all absorbance measurements are made within a 10 minute period. 6. Subtract the average 562 nm absorbance reading of the Blank standard replicates from the 562 nm reading of all other individual standard and unknown sample replicates. 7. Prepare a standard curve by plotting the average Blank-corrected 562 nm reading for each BSA standard vs. its concentration in µg/ml. Use the standard curve to determine the protein concentration of each unknown sample. Microplate Procedure (linear working range of 2-40 µg/ml) 1. Pipette 150 µl of each standard or unknown sample replicate into a microplate well (Product No. 15041). 2. Add 150 µl of the WR to each well and mix plate thoroughly on a plate shaker for 30 seconds. 3. Cover plate using Sealing Tape for 96-Well Plates (Product No. 15036) and incubate at 37°C for 2 hours. Note: Limit incubations of microplate to less than or equal to 37°C, otherwise high background and aberrant color development may result. Most polystyrene assay plates deform, leach, and become cloudy at 60°C. 4. Cool plate to room temperature (RT). 5. Measure the absorbance at or near 562 nm on a plate reader. 6. Subtract the average 562 nm absorbance reading of the Blank standard replicates from the 562 nm reading of all other individual standard and unknown sample replicates. 7. Prepare a standard curve by plotting the average Blank-corrected 562 nm reading for each BSA standard vs. its concentration in µg/ml. Use the standard curve to determine the protein concentration of each unknown sample. Note: If using curve-fitting software, use a best-fit polynomial equation rather than a linear equation for the standard curve. If plotting results by hand, a point-to-point fit is preferable to a linear fit to the standard points. Troubleshooting Problem Possible Cause Solution No color in any tubes Sample contains a copper chelating agent Dialyze, desalt, or dilute sample Increase copper concentration in working reagent (e.g., use more Reagent MC) Strong acid or alkaline buffer, alters working reagent pH Dialyze, desalt, or dilute sampleBlank absorbance is OK, but standards and samples show less color than expected Color measured at the wrong wavelength Measure the absorbance at 562 nm Protein concentration is too high Dilute sampleColor of samples appears darker than expected Sample contains lipids or lipoproteins Add 2% SDS to the sample3 Buffer contains a reducing agent Buffer contains a thiol All tubes (including blank) are dark purple Buffer contains biogenic amines (catecholamines) Dialyze or dilute sample Need to measure color at a different wavelength Spectrophotometer or plate reader does not have 562 nm filter Wavelengths between 540 nm and 590 nm can be used, but standard curve slope and overall assay sensitivity will be decreased. See Tech Tip on web site
  • 4. Additional Information A. Interfering Substances Certain substances are known to interfere with the Micro BCA Assay including those with reducing potential, chelating agents, and strong acids or bases. Avoid the following substances as components of the sample buffer: Ascorbic Acid Hydrogen Peroxide Iron Reducing Sugars Catecholamines Hydrazides Lipids Tryptophan Cysteine Impure Glycerol Phenol Red Tyrosine EGTA Impure Sucrose Reducing Agents Uric Acid Maximum compatible concentrations for many substances in the Test Tube Procedure are listed in Table 2 (see last page). Substances were considered compatible at the indicated concentration if the error in protein concentration estimation caused by the presence of the substance in the sample was less than or equal to 10%. The substances were tested using WR prepared immediately before each experiment. The Blank-corrected 562 nm absorbance measurements (for the 10 µg/ml BSA standard + substance) were compared to the net 562 nm readings of the same standard prepared in 0.9% saline. B. Strategies for Eliminating or Minimizing the Effects of Interfering Substances The effects of interfering substances in the Micro BCA Protein Assay may be eliminated or overcome by several methods. • Remove the interfering substance by dialysis or gel filtration (see Related Pierce Products). • Dilute the sample until the substance no longer interferes. (This is only effective for relatively concentrated samples.) • Precipitate proteins with acetone or trichloroacetic acid (TCA).4 • Increase the amount of copper in the WR (prepare WR using a greater proportion of Reagent MC; e.g., MA:MB:MC equal to 25:24:2 or 25:24:3), which may eliminate interference by copper chelating agents. Note: For greatest accuracy, the protein standards must be treated identically to the sample(s). C. Response Characteristics for Different Proteins Each of the commonly used total protein assay methods exhibits some degree of varying response toward different proteins (Table 3). These differences relate to amino acid sequence, pI, structure and the presence of certain side chains or prosthetic groups that can dramatically alter the protein’s color response. Most protein assay methods use BSA or immunoglobulin (IgG) as the standard against which the concentration of protein in the sample is determined. Pierce Albumin Standard (BSA) (Product No. 23209) provides a consistent standard for protein estimations. Nevertheless, individual proteins, including BSA and IgG, differ slightly in their color responses in the Micro BCA Assay (Figure 1). Therefore, for maximum accuracy use a purified (known concentration) sample of the target protein as the assay standard. Table 3. Protein-to-Protein Variation. Absorbance ratios (562 nm) for proteins relative to BSA using the Test Tube Procedure. Ratio = (avg. “test” net Abs.) / (avg. BSA net Abs.) Protein Tested Ratio Albumin, bovine serum 1.00 Aldolase, rabbit muscle 0.80 α-Chymotrypsinogen, bovine 0.99 Cytochrome C, horse heart 1.11 Gamma globulin, bovine 0.95 IgG, bovine 1.12 IgG, human 1.03 IgG, mouse 1.23 IgG, rabbit 1.12 IgG, sheep 1.14 Insulin, bovine pancreas 1.22 Myoglobin, horse heart 0.92 Ovalbumin 1.08 Transferrin, human 0.98 Average Ratio 1.05 Figure 1. Typical color response curves for BSA and BGG using the Test Tube Procedure. Standard Deviation 0.12 Coefficient of Variation 11.4% Pierce Biotechnology PO Box 117 (815) 968-0747 www.thermo.com/pierce 3747 N. Meridian Road Rockford, lL 61105 USA (815) 968-7316 fax 4
  • 5. Pierce Biotechnology PO Box 117 (815) 968-0747 www.thermo.com/pierce 3747 N. Meridian Road Rockford, lL 61105 USA (815) 968-7316 fax 5 D. Alternative Total Protein Assay Reagents If interference by a reducing substance or metal-chelating substance contained in the sample cannot be overcome, try the Coomassie Plus (Bradford) Protein Assay Kit (Product No. 23236), which is less sensitive to such substances. E. Cleaning and Re-using Glassware Care must be exercised when re-using glassware. The Micro BCA WR is sensitive to metal ions, especially copper ions. All glassware must be cleaned and then given a thorough final rinse with ultrapure water. Related Thermo Scientific Products 15041 Pierce 96-Well Plates, 100/pkg. 15075 Reagent Reservoirs, 200/pkg. 15036 Sealing Tape for 96-Well Plates, 100/pkg. 23209 Albumin Standard Ampules, 2 mg/ml, 10 × 1 ml ampules, containing bovine serum albumin (BSA) 23212 Bovine Gamma Globulin Standard, 2 mg/ml, 10 × 1 ml ampules, containing bovine gamma globulin 23236 Coomassie Plus (Bradford) Protein Assay Kit, working range 1-1,500 μg/ml 89882 Zeba™ Desalt Spin Columns, 0.5 ml, for desalting 20-130 µl samples 89889 Zeba Desalt Spin Columns, 2 ml, for desalting 200-700 µl samples 69576 Slide-A-Lyzer® MINI Dialysis Units, 10 units and float for dialyzing 10-100 µl samples 69576 Slide-A-Lyzer Dialysis Cassettes, 10 units and floats for 100-500 µl samples Cited References 1. Smith, P.K., et al. (1985). Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76-85. 2. Wiechelman, et al. (1988). Investigation of the bicinchoninic acid protein assay: Identification of the groups responsible for color formation. Anal Biochem. 175:231-7. 3. Kessler, R. and Fanestil, D. (1986). Interference by lipids in the determination of protein using bicinchoninic acid. Anal. Biochem. 159:138-42. 4. Brown, R., et al. (1989). Protein measurement using bicinchoninic acid: elimination of interfering substances. Anal. Biochem. 180:136-9. Product References O'Nuallain, B. and Wetzel, R. (2002). Conformational Abs recognizing a generic amyloid fibril epitope. Proc. Natl. Acad. Sci. USA 99:1485-90. Paratcha, G., et al. (2003). The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands. Cell 113:867-79. Gembitsky, D.S., et al. (2004). A prototype antibody microarray platform to monitor changes in protein tyrosine phosphorylation. Mol. Cell. Proteomics 3:1102-1118. Yang, G., et al. (2005). Activation-induced deaminase cloning, localization, and protein extraction from young Vh-mutant rabbit appendix. Proc. Natl. Acad. Sci. USA 102:17083-8. Slide-A-Lyzer® Dialysis Cassette Technology is protected by U.S. Patent # 5,503,741 and 7,056,440. Slide-A-Lyzer® MINI Dialysis Unit Technology is protected by U.S. Patent # 6,039,871. Triton® is a registered trademark of Rohm & Haas Co. Brij® , Tween® and Span® are registered trademarks of ICI Americas. Zwittergent® is a registered trademark of American Hoechst Corporation. This product (“Product”) is warranted to operate or perform substantially in conformance with published Product specifications in effect at the time of sale, as set forth in the Product documentation, specifications and/or accompanying package inserts (“Documentation”) and to be free from defects in material and workmanship. Unless otherwise expressly authorized in writing, Products are supplied for research use only. No claim of suitability for use in applications regulated by FDA is made. The warranty provided herein is valid only when used by properly trained individuals. Unless otherwise stated in the Documentation, this warranty is limited to one year from date of shipment when the Product is subjected to normal, proper and intended usage. This warranty does not extend to anyone other than the original purchaser of the Product (“Buyer”). No other warranties, express or implied, are granted, including without limitation, implied warranties of merchantability, fitness for any particular purpose, or non infringement. Buyer’s exclusive remedy for non-conforming Products during the warranty period is limited to replacement of or refund for the non-conforming Product(s). There is no obligation to replace Products as the result of (i) accident, disaster or event of force majeure, (ii) misuse, fault or negligence of or by Buyer, (iii) use of the Products in a manner for which they were not designed, or (iv) improper storage and handling of the Products. Current versions of product instructions are available at www.thermo.com/pierce. For a faxed copy, call 800-874-3723 or contact your local distributor. © 2008 Thermo Fisher Scientific Inc. All rights reserved. Unless otherwise indicated, all trademarks are property of Thermo Fisher Scientific Inc. and its subsidiaries. Printed in the USA.
  • 6. Pierce Biotechnology PO Box 117 (815) 968-0747 www.thermo.com/pierce 3747 N. Meridian Road Rockford, lL 61105 USA (815) 968-7316 fax 6 Table 2. Compatible Substance Concentrations in the Micro BCA Protein Assay (see text for details). Substance Compatible Concentration Salts/Buffers ACES, pH 7.8 10 mM Ammonium sulfate -------- Bicine, pH 8.4 2 mM Bis-Tris, pH 6.5 0.2 mM Borate (50 mM), pH 8.5 (#28384) 1:4 dilution* B-PER ® Reagent (#78248) 1:10 dilution* Calcium chloride in TBS, pH 7.2 10 mM Na-Carbonate/Na-Bicarbonate (0.2 M), pH 9.4 (#28382) undiluted Cesium bicarbonate 100 mM CHES, pH 9.0 100 mM Na-Citrate (0.6 M), Na-Carbonate (0.1 M), pH 9.0 (#28388) 1:600 dilution* Na-Citrate (0.6 M), MOPS (0.1 M), pH 7.5 (#28386) 1:600 dilution* Cobalt chloride in TBS, pH 7.2 -------- EPPS, pH 8.0 100 mM Ferric chloride in TBS, pH 7.2 0.5 mM Glycine n/a Guanidine•HCl 4 M HEPES, pH 7.5 100 mM Imidazole, pH 7.0 12.5 mM MES, pH 6.1 100 mM MES (0.1 M), NaCl (0.9%), pH 4.7 (#28390) 1:4 dilution* MOPS, pH 7.2 100 mM Modified Dulbecco’s PBS, pH 7.4 (#28374) undiluted Nickel chloride in TBS, pH 7.2 0.2 mM PBS; Phosphate (0.1 M), NaCl (0.15 M), pH 7.2 (#28372) undiluted PIPES, pH 6.8 100 mM RIPA lysis buffer; 50 mM Tris, 150 mM NaCl, 0.5% DOC, 1% NP-40, 0.1% SDS, pH 8.0 1:10 dilution* Sodium acetate, pH 4.8 200 mM Sodium azide 0.2% Sodium bicarbonate 100 mM Sodium chloride 1 M Sodium citrate, pH 4.8 (or pH 6.4) 5 mM (16.7 mM) Sodium phosphate 100 mM Tricine, pH 8.0 2.5 mM Triethanolamine, pH 7.8 0.5 mM Tris 50 mM TBS; Tris (25 mM), NaCl (0.15 M), pH 7.6 (#28376) 1:10 dilution* Tris (25 mM), Glycine (192 mM), pH 8.0 (#28380) 1:10 dilution* Tris (25 mM), Glycine (192 mM), SDS (0.1%), pH 8.3 (#28378) undiluted Zinc chloride in TBS, pH 7.2 0.5 mM Substance Compatible Concentration Detergents** Brij ® -35 5.0% Brij-56, Brij-58 1.0% CHAPS (CHAPSO) 1.0% (5.0%) Deoxycholic acid 5.0% Nonidet P-40 (NP-40) 5.0% Octyl β-glucoside 0.1% Octyl β-thioglucopyranoside 5.0% SDS 5.0% Span ® 20 1.0% Triton ® X-100 5.0% Triton X-114 0.05% Triton X-305, X-405 1.0% Tween ® -20, Tween-80 5.0% Tween-60 0.5% Zwittergent ® 3-14 -------- Chelating agents EDTA 0.5 mM EGTA -------- Sodium citrate, pH 4.8 (or pH 6.4) 5 mM (16.7 mM) Reducing & Thiol-Containing Agents N-acetylglucosamine in PBS, pH 7.2 -------- Ascorbic acid -------- Cysteine -------- Dithioerythritol (DTE) -------- Dithiothreitol (DTT) -------- Glucose 1 mM 2-Mercaptoethanol 1 mM Thimerosal -------- Misc. Reagents & Solvents Acetone 1.0% Acetonitrile 1.0% Aprotinin 1 mg/L DMF, DMSO 1.0% Ethanol 1.0% Glycerol (Fresh) 1.0% Hydrazide -------- Hydrides (Na2BH4 or NaCNBH3) -------- Hydrochloric Acid 10 mM Leupeptin 10 mg/L Methanol 1.0% Phenol Red -------- PMSF 1 mM Sodium Hydroxide 50 mM Sucrose 4% TLCK 0.1 mg/L TPCK 0.1 mg/L Urea 3 M o-Vanadate (sodium salt), in PBS, pH 7.2 1 mM * Diluted with ultrapure water ** Detergents were tested using Pierce high-purity Surfact-Amps ® Products, which have low peroxide content --- Dashed-line entry indicates that the material is incompatible with the assay